BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8142207)

  • 1. Mechanisms of proteinuria in nephrotic humans.
    Myers BD; Guasch A
    Pediatr Nephrol; 1994 Feb; 8(1):107-12. PubMed ID: 8142207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of the glomerular filtration barrier in healthy and nephrotic humans.
    Myers BD; Guasch A
    Am J Nephrol; 1993; 13(5):311-7. PubMed ID: 8116683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans.
    Deen WM; Bridges CR; Brenner BM; Myers BD
    Am J Physiol; 1985 Sep; 249(3 Pt 2):F374-89. PubMed ID: 4037090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
    Carrie BJ; Myers BD
    Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of proteinuria in immune glomerular injury.
    Myers BD
    Am J Nephrol; 1990; 10 Suppl 1():19-23. PubMed ID: 1701613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal change nephropathy: an electrochemical disorder of the glomerular membrane.
    Carrie BJ; Salyer WR; Myers BD
    Am J Med; 1981 Feb; 70(2):262-8. PubMed ID: 6162382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular charge alterations in human minimal change nephropathy.
    Bridges CR; Myers BD; Brenner BM; Deen WM
    Kidney Int; 1982 Dec; 22(6):677-84. PubMed ID: 6186837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans.
    Shemesh O; Deen WM; Brenner BM; McNeely E; Myers BD
    Kidney Int; 1986 Apr; 29(4):916-23. PubMed ID: 3712975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and consequences of proteinuria.
    Kaysen GA; Myers BD; Couser WG; Rabkin R; Felts JM
    Lab Invest; 1986 May; 54(5):479-98. PubMed ID: 3517485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules.
    Bohrer MP; Baylis C; Robertson CR; Brenner BM; Troy JL; Willis WT
    J Clin Invest; 1977 Jul; 60(1):152-61. PubMed ID: 874080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of the glomerular barrier and mechanisms of proteinuria.
    Haraldsson B; Nyström J; Deen WM
    Physiol Rev; 2008 Apr; 88(2):451-87. PubMed ID: 18391170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of proteinuria in diabetic glomerular disease.
    Myers BD
    J Hypertens Suppl; 1990 Mar; 8(1):S41-6. PubMed ID: 2332816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of glomerular charge selectivity in man by differential clearance of isoamylases.
    Fox JG; Quin JD; O'Reilly DS; Boulton-Jones JM
    Clin Sci (Lond); 1993 Apr; 84(4):449-54. PubMed ID: 7683259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance ratios of amylase isoenzymes and IgG subclasses: do they reflect glomerular charge selectivity?
    Buis B; Wever PC; Koomen GC; van Acker BA; Groothoff JW; Krediet RT; Arisz L
    Nephron; 1997; 75(4):444-50. PubMed ID: 9127332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular permselectivity: barrier function based on discrimination of molecular size and charge.
    Brenner BM; Hostetter TH; Humes HD
    Am J Physiol; 1978 Jun; 234(6):F455-60. PubMed ID: 665772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overlapping syndrome of IgA nephropathy and lipoid nephrosis.
    Lai KN; Lai FM; Chan KW; Ho CP; Leung AC; Vallance-Owen J
    Am J Clin Pathol; 1986 Dec; 86(6):716-23. PubMed ID: 3538845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent insights into the pathogenesis of nephrotic syndrome.
    Certikova-Chabova V; Tesar V
    Minerva Med; 2013 Jun; 104(3):333-47. PubMed ID: 23748287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular proteinuria in renal transplant patients: mechanisms and treatment.
    Barnas U; Mayer G
    Kidney Int Suppl; 1997 Dec; 63():S78-80. PubMed ID: 9407428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.